热门资讯> 正文
2020-02-28 05:39
TrovaGene (NASDAQ:TROV): Q4 GAAP EPS of -$0.51 beats by $0.14.
Revenue of $0.09M (+12.5% Y/Y)
Shares -4.07%.
Press Release